IL-1 Inhibition and Function of the HDL-Containing Fraction of Plasma in Patients with Stages 3 to 5 CKD

BACKGROUND AND OBJECTIVES: Systemic inflammation modulates cardiovascular disease risk and functionality of HDL in the setting of CKD. Whether interventions that modify systemic inflammation can improve HDL function in CKD is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a...

Full description

Saved in:
Bibliographic Details
Published in:Clin J Am Soc Nephrol
Main Authors: Hung, Adriana M., Tsuchida, Yohei, Nowak, Kristen L., Sarkar, Sudipa, Chonchol, Michel, Whitfield, Victoria, Salas, Natjalie, Dikalova, Anna, Yancey, Patricia G., Huang, Jiansheng, Linton, MacRae F., Ikizler, T. Alp, Kon, Valentina
Format: Artigo
Language:Inglês
Published: American Society of Nephrology 2019
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6500942/
https://ncbi.nlm.nih.gov/pubmed/31015261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.04360418
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items